- Home
- UNB vs BDTX Comparison
UNB vs BDTX Comparison
Compare UNB & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | UNB | BDTX |
|---|---|---|
| Founded | 1891 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 104.1M | 116.8M |
| IPO Year | 1999 | 2020 |
Fundamental Metrics
Financial Performance| Metric | UNB | BDTX |
|---|---|---|
| Price | $23.63 | $2.07 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $10.20 |
| AVG Volume (30 Days) | 4.9K | ★ 577.6K |
| Earning Date | 04-15-2026 | 03-16-2026 |
| Dividend Yield | ★ 6.19% | N/A |
| EPS Growth | 25.52 | ★ 130.71 |
| EPS | ★ 2.41 | 0.39 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $9.65 | ★ $5.21 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $20.65 | $1.20 |
| 52 Week High | $34.85 | $4.94 |
Technical Indicators
Market Signals| Indicator | UNB | BDTX |
|---|---|---|
| Relative Strength Index (RSI) | 50.44 | 41.99 |
| Support Level | $23.54 | $1.93 |
| Resistance Level | $25.02 | $2.30 |
| Average True Range (ATR) | 0.65 | 0.11 |
| MACD | 0.05 | -0.00 |
| Stochastic Oscillator | 67.11 | 25.00 |
Price Performance
Historical ComparisonAbout UNB Union Bankshares Inc.
Union Bankshares Inc operates as a community bank in the financial services industry. It offers retail and commercial banking services to its customers through its branches, ATMs, telebanking, and internet banking systems. The company provides retail banking services to individuals and commercial banking services to small and medium-sized corporations, partnerships, and sole proprietorships, as well as nonprofit organizations, local municipalities, and school districts within its market area. In addition, it also offers fiduciary and asset management services through its Asset Management Group.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.